Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-Effect Study of E7386 in Healthy Subjects
NCT03996226Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of e7386 in solid tumor (2 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration, Time to Reach Maximum Observed Plasma Concentration and 2 more. Started Jun 2019; status: completed.
02
Drugs
e7386
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03996226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996226.